DobbieJ.W.Pathology of the peritoneum. In: BengmarkS., ed. The peritoneum and peritoneal access.London: Wright, 1989: 42–52.
2.
OtaK., MineshimaM., WatanabeN.Functional deterioration of the peritoneum: Does it occur in the absence of peritonitis?Nephrol Dial Transplant1987; 2: 30–3.
3.
DuweA.K., VasS.I., WeatherheadJ.W.Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro.Infect Immun1981; 33: 130–5.
4.
AlobaidiH.M., ColesG.A., DaviesM.Host defense in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function.Nephrol Dial Transplant1986; 1: 16–21.
5.
Van BronswijkH., VerbrughH.A., BosH.J.Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro.Perit Dial Int1989; 9: 197–202.
6.
WieslanderA.P., NordinM.K., KjellstrandP.T.T.Toxicity of peritoneal dialysis fluids on cultured fibroblasts L-929.Kidney Int1991; 40: 77–9.
7.
Fernandez -ReyesM.J., SelgasR., BosqueE.Prospective study of peritoneal function in long-term CAPD patients.Perit Dial Int1992; 12(Suppl 1): 159A.
8.
TopleyN., AlobaidiH.M., DaviesM.The effect of dialysate on peritoneal phagocyte oxidative metabolism.Kidney Int1988; 34: 404–11.
NathanC.F.Secretory products of macrophages.J Clin Invest1987; 79: 319–26.
11.
Di PaoloN., SacchiG., VanniL.Implant of autologous mesothelial cells in animals and a peritoneal dialysis patient.Int J ArtifOrgans1989; 12: 485501.
12.
BreborowiczA., BalaskasE., DiamandisE.Effect of tumor necrosis factor on human mesothelial cells in in vitro culture.Perit Dial Int1992; 12(Suppl 2): S6A.
